Prescription Drugs Are More Expensive in Rep. Waxman's Congressional District in California than in Canada, Europe, and Japan

Thumbnail Image
Serial Number
Levin Center Identifier
Document Date
Report Length
14 pages
Policy Agendas Project Major Code
Policy Agendas Project Minor Code
Additional, Minority, Dissenting Views
Found Using Methodology
Idependent Author(s)
Brief Executive Summary
The Special Investigations Division of the House Committee on Government Reform examined the financial impact of high prescription drug prices on senior citizens in the United States, particularly those without Medicare coverage for drugs. The report attributes the high drug prices to price discrimination by manufacturers, a practice not addressed in the U.S. compared to other developed countries. The investigation specifically focuses on Rep. Waxman's congressional district, comparing the prices paid by seniors for popular brand-name prescription drugs with prices in Canada, France, Germany, Italy, Japan, and the United Kingdom.
Press Releases and Contextual Information
Related Hearings
Authors–Congress Members
Authors–Staff Members
Authors–Ex Officio Members
Authors–Additional, Minority, Dissenting Views